雅虎香港 搜尋

  1. tsla stock price 相關

    廣告
  2. Which of the Magnificent 7 stocks are worth buying? Which should you sell? Find out here. What's next for the Magnificent 7 stocks? Find out in our urgent report. It's free today.

搜尋結果

  1. 5 小時前 · Tesla's (NASDAQ:TSLA) CEO Elon Musk revealed on Tuesday that the company expects to spend between $3 billion and $4 billion on hardware purchases from chipmaker Nvidia (NASDAQ:NVDA) this year. This spending forms a significant portion of Tesla's $10 billion allocated for artificial intelligence (AI) capital expenditure in 2024.

  2. 42 分鐘前 · Tesla shares are trading in a technical pattern and are ready to break out from consolidation. TSLA – Daily Chart. TSLA stock trades in a triangle formation, which has tightened and looks ready to break out. Support for a lower move costs $160.68, and the higher resistance is $200-205. Elon Musk was under some pressure again after reports ...

  3. 其他人也問了

  4. 4 小時前 · Tesla Stock Performance TSLA shares edged down 0.8% to 174.97 on the stock market today. Tesla stock dropped 1% to 176.29 on Monday. TSLA shares dropped 2.8% in May and have sunk around 30% so far ...

  5. 1 天前 · Specifically, the Tesla (NASDAQ: TSLA) CEO estimates that the electric vehicle (EV) firm will spend between $3 and $4 billion on chips from Nvidia in 2024. This news is helping send NVDA stock up.

  6. 7 小時前 · Institutional shareholders are reducing their positions in Tesla, citing concerns about future growth. Tesla's stock has dropped nearly 30% this year and over 50% since its 2021 peak. Wall Street analysts maintain a positive outlook, with many rating the stock as a "buy" or "strong buy." Tesla's stock decline is attributed to increased ...

  7. 1 天前 · 据报道,特斯拉 (TSLA.US)投资者、挪威最大的养老基金KLP计划投票赞成一项股东提案,该提案敦促这家美国电动汽车制造商在瑞典继续面临劳工行动 ...

  8. 1 天前 · 2024-06-04 16:38. Tuesday, Oppenheimer increased its price target on Crinetics Pharmaceuticals ( NASDAQ : NASDAQ: CRNX ) to $74 from $55, while maintaining an Outperform rating on the stock. The adjustment follows recent data showcasing the effectiveness of Crinetics' drug candidate, atumelnant, in treating patients with congenital adrenal ...

  1. 其他人也搜尋了